Form D · Biotechnology
Provention Bio, Inc.
Lebanon, NJ · CIK 0001695357
Offering snapshot reported May 4, 2017 · SEC filing
- Reported sold
- $28.5M Offering amount: $30M
- Investors reported
- 158 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 25, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2017 | Initial | $28,454,995 | No comparison | 158 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.4M
- Finders' fees
- $0
- Form D file number
- 021-286073
Offering is closed.
Series A Preferred Stock
Excludes value of warrants to purchase up to 558,740 shares of Series A Preferred Stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MDB Capital Group, LLC | 42677 | |
| Paulson Investment Company, LLC | 5670 |
Source: Form D, filed May 4, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Di Giandomenico | Director |
| Cameron Gray | Director |
| Francisco Leon, M.D. | Director |
| Ashleigh Palmer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
110 Old Driftway Lane
Lebanon, NJ, 08833
Lebanon, NJ, 08833